宇学峰于2009年1月担任
康希诺生物董事长和
首席执行官。
人物经历
宇学峰在
生物医药领域深耕30多年。在加入
康希诺生物之前,宇学峰曾就职于
加拿大IBEX Biotechnologies
Inc.,任产品研发科学家,从事药用
酶制剂的研发;1998年加入全球五大疫苗企业之一
赛诺菲巴斯德(Sanofi Pasteur Limited.),先后担任产品开发部科学家、
细菌疫苗开发部加拿大分部总监及细菌疫苗开发全球总监。
创办康希诺生物十多年来,宇学峰不断吸引国内外疫苗行业的顶尖人士加入,为康希诺生物组建了一支顶尖人才队伍,带领
团队建立了针对12种疾病的17款疫苗产品的研发管线,其中
重组埃博拉病毒病疫苗(Ad5-EBOV)于2017年获批上市,成为
亚洲首个获批的重组埃博拉病毒病疫苗。2021年2月25日,康希诺生物研发的
重组新型冠状病毒疫苗(5型腺病毒载体)克威莎® 获得国家药品监督管理局批准
附条件上市,成为中国首个获批的
腺病毒载体新冠疫苗。
同时,宇学峰还主导建设了康希诺生物疫苗产业化生产基地,其设计、建设和运营均符合国际
GMP标准。
主要贡献
成功的完成了三个新疫苗(人乳头瘤病毒疫苗,
炭疽重组蛋白疫苗,
衣原体重组蛋白疫苗)的
临床前研发,四个新疫苗(
中耳炎疫苗,
肺炎重组蛋白疫苗,7和13价肺炎
结合疫苗)的临床1期研发,两个新疫苗(
肺结核重组蛋白疫苗,老年肺炎重组蛋白疫苗)的临床2期研发。
1. Yu, X. Application of Innovative Technologies to Vaccine Process Development. Invited panel presentation, IBC 2nd Annual Vaccine Asia conference. Nov 10-13, 2008. Beijing, China。
2. Yu, X. Leverage key Success Factors to Strategically Develop an Effective Technology Transfer Process. Invited speaker, CMO Partnerships for Successful Technology Transfer. July 30- August 1, 2007, Institute of International Research, Boston,
MA.
3. Yu, X. Application of PAT principals in Process Development in Sanofi Pasteur, Invited
speaker. IBC’s 3rd International Implementing Process Analytical Technologies (PAT) for Bioprocessing July 17-19, 2006, Reston, Virginia。
4. Matheson, K.; Yu, X. Evaluation of microarray technology as a tool for host strain assessment and process optimization. Invited speaker and session Chairman, Recent Advances in Fermentation Technology (RAFT IV) Nov 6-9 2005, Long Beach,
CA.
5. Yu, X.; D’Amore, T. Fermentation Process Development to Optimize Recombinant Proteins Expression in Escherichia coli, Recent Advances in Fermentation Technology (RAFT III), Nov. 2001, Sarasota, FL.
6. Yu, X.; D’Amore, T. Fermentation Process Development to Optimize Recombinant Protein Expression in E. coli for Otitis Media Vaccine Production, SIM Annual meeting, July 200。
7. Yu, X.; Hallett, S. G.; Sheppard, J.; Watson, A. K. Effects of carbon concentration and carbon-to-nitrogen ratio on growth, conidiation, spore germination and efficacy of the potential bioherbicide Colletotrichum coccodes. Journal of
Industrial Microbiology & Biotechnology (1998), 20(6), 333-338.
8. Yu, X.; Hallet, S. G.; Sheppard, J.; Watson, A. K. Application of the Plackett-Burman experimental design to evaluate nutritional requirements for the production of Colletotrichum coccodes spores. Applied Microbiology and Biotechnology (1997), 47(3), 301-305.
9. Yu, X.; Gu, K. High Cell Density Fermentation of Recombinant E. coli Expressing Phenylalanine Ammonia Lyase, IBEX Technologies Inc., Montreal, QC, Canada, Recent Advances in Fermentation Technology (RAFT II), Nov 1997, San Diego, CA。
10. Yu, X., Hallett, S., Sheppard, J. and Watson A.K. Production of Spores of Colletotrichum coccodes in a Cyclone Column Bioreactor, Canadian Society for Microbiology Annual Meeting, July 1995, Kingstown, Canada。
11. Yu, X, Hallett, S. and Watson, A.K. Development of an efficient and cost effective growth medium for Colletotrichum coccodes. II International Bioherbicides Workshop, 1992, Montreal, Canad。
12. Zhou, Y.L., Shi, G.L., Zhou,
J.Y., Long, T.J., Li, M.L., Yu, X. and Zhang, J., 1991, Yeasts of Bohai Seawater. Acta Mycologica Sinica, Vol.10(1), 36-42。
13. Zhou, Y.L., Xing, L.J., Wang, Y.X., Liu, R.L., Wang, H.M., Yu, X. and Liu, F. 1990, High-protein Content of Strains of Fusarium for Food Potentials. The Fourth International Mycological Congress, FRG。
14. Zhou, Y.L., Xing, L.J., Wang, H.M., Yu, X. and Liu, F. 1990, Studies on Nutrient Condition for Protein-producing Fusarium. The Third National Symposium on Fungi and Lichens, Mycological Society of China Beijing。
15. Yu, X., Song, L.S. and Wang, Y.W., 1990, Auxotroph Selection of Aureobasidium pullulans and the Formation and Regeneration of its Protoplast. Acta Scientiarum Naturalium Universitatis Nankaiensis No.1, 101-103。
16. Wang, Y.W., Yu, X., Wang, H.M., Song, L.S. and Zhou, Y.L., 1990, Electric Field-induced Intergeneric Protoplast Fusion Between Saccharomyces cerevisiae and Aureobasidium pullulans. Acta Mycologica Sinica, Vol.9(1), 56-63.
17. Zhou, Y.L., Li, M.L., Wang, H.M., Yu, X., Liu, F., Zhang J. and Hu G., 1990, Yeasts From Different Substrata Along Bohai Seacoast. Acta Scientiarum Naturalium Universitatis Nankaiensis, No.4, 57-61.
职务任免
2022年8月2日,
津商联合会正式宣布成立,出任津商联合会共同主席。
获得荣誉
2019年,担任
天津市
生物医药产业专家 咨询委员会委员
2019年3月,担任南开大学特聘教授
2020年12月,被评选为“天津市发改委决策咨询专家”
2020年12月,被评选为
创业邦2020年度创业人物
2021年10月,入选天津市企业家队伍建设“111”工程“杰出企业家”培养对象
研究方向
招生方向:药理学。
财富排名
2021年4月,宇学峰以12亿美元财富位列《2021福布斯全球富豪榜》第2378位。
社会职务